MCAC Panel Decision Postponed Following Chair's "No Confidence" Vote
This article was originally published in The Gray Sheet
Executive Summary
A dissenting opinion by Medicare Coverage Advisory Committee's Drugs, Biologics, and Therapeutics Panel Chair Thomas Holohan, MD, Department of Veterans Affairs, effectively nullified a unanimous recommendation by his panel supporting coverage of stem cell transplantation for multiple myeloma.